These measurements, as well as being a clear target for people with T1DM or T2DM, have been agreed upon by an International Consensus Group (Supplementary Table 1).26 Separate targets have been recommended also for women with T1DM during pregnancy and for people who are at higher risk of hypoglycaemia because of age, duration of diabetes, duration of insulin therapy or impaired awareness of hypoglycaemia. The gene discussed is INS; the disease is diabetes mellitus.